Cancyte


Cancyte is a company dedicated to developing modern molecular and genomic-based diagnostic tests for detecting and treating various types of cancer and infectious diseases. With access to senior scientists, pathologists, and oncologists worldwide, Cancyte aims to provide affordable, quality molecular diagnostics through world-class NABL-ILAC accredited laboratories. The company's mission is to translate basic research into clinical applications, offering reliable diagnostics and continuing research to improve patient care.

Industries

health-care
health-diagnostics
medical

Nr. of Employees

small (1-50)

Cancyte


Services

Laboratory PCR testing for infectious pathogens including HIV, Chikungunya, Malaria, HBV, HCV, Dengue and H1N1.

Quantitative nucleic acid testing services for monitoring viral load (examples provided for HIV, HBV, HCV).

Immunoassays and rapid tests including ELISA and point-of-care rapid tests for HIV, HBV, HCV and Dengue (NS1, IgM, IgG).

Molecular HLA typing services for donor registries and transplant support; historical throughput reported for large donor cohorts.

Screening tests intended for newborns to detect congenital or early-life conditions.

Laboratory testing for cancer biomarkers to support clinical evaluation.

Expertise Areas

  • Molecular diagnostics
  • Infectious disease diagnostics
  • Oncology/genomic biomarker testing
  • HLA typing and transplant diagnostics
  • Show More (3)

Key Technologies

  • Polymerase chain reaction (PCR)
  • Quantitative viral load assays (qPCR/NAAT)
  • ELISA and serology assays
  • Rapid diagnostic tests (point-of-care serology/antigen)
  • Show More (4)

News & Updates

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.